Regulatory T cells in the mouse hypothalamus control immune activation and ameliorate metabolic impairments in high-calorie environments

M Maike Becker S Stefanie Kälin A Anne H. Neubig M Michael Lauber D Daria Opaleva H Hannah Hipp V Victoria K. Salb V Verena B. Ott B Beata Legutko R Roland E. Kälin M Markus Hippich M Martin G. Scherm L Lucas F. R. Nascimento I Isabelle Serr F Fabian Hosp A Alexei Nikolaev A Alma Mohebiany M Martin Krueger B Bianca Flachmeyer M Michael W. Pfaffl B Bettina Haase C Chun-Xia Yi S Sarah Dietzen T Tobias Bopp S Stephen C. Woods A Ari Waisman (Institute for Molecular Medicine and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.) B Benno Weigmann M Matthias Mann M Matthias H. Tschöp C Carolin Daniel

Abstract

Abstract The hypothalamus in the central nervous system (CNS) has important functions in controlling systemic metabolism. A calorie-rich diet triggers CNS immune activation, impairing metabolic control and promoting obesity and Type 2 Diabetes (T2D), but the mechanisms driving hypothalamic immune activation remain unclear. Here we identify regulatory T cells (Tregs) as key modulators of hypothalamic immune responses. In mice, calorie-rich environments activate hypothalamic CD4 + T cells, infiltrating macrophages and microglia while reducing hypothalamic Tregs. mRNA profiling of hypothalamic CD4 + T cells reveals a Th1-like activation state, with increased Tbx21 , Cxcr3 and Cd226 but decreased Ccr7 and S1pr1 . Importantly, results from Treg loss-of function and gain-of-function experiments show that Tregs limit hypothalamic immune activation and reverse metabolic impairments induced by hyper-caloric feeding. Our findings thus help refine the current model of Treg-centered immune-metabolic crosstalk in the brain and may contribute to the development of precision immune modulation for obesity and diabetes.

Article Details

Volume / Issue Vol. 16, Issue 1
Published March 20, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (30)

M

Maike Becker

S

Stefanie Kälin

A

Anne H. Neubig

M

Michael Lauber

D

Daria Opaleva

H

Hannah Hipp

V

Victoria K. Salb

V

Verena B. Ott

B

Beata Legutko

R

Roland E. Kälin

M

Markus Hippich

M

Martin G. Scherm

L

Lucas F. R. Nascimento

I

Isabelle Serr

F

Fabian Hosp

A

Alexei Nikolaev

A

Alma Mohebiany

M

Martin Krueger

B

Bianca Flachmeyer

M

Michael W. Pfaffl

B

Bettina Haase

C

Chun-Xia Yi

S

Sarah Dietzen

T

Tobias Bopp

S

Stephen C. Woods

A

Ari Waisman

Institute for Molecular Medicine and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany.

B

Benno Weigmann

M

Matthias Mann

M

Matthias H. Tschöp

C

Carolin Daniel